Human Cytochrome P450 and Personalized Medicine

被引:8
|
作者
Chen, Qi [1 ]
Wei, Dongqing [1 ]
机构
[1] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China
来源
关键词
Personalized medicine; SNPs; CYP450; SINGLE NUCLEOTIDE POLYMORPHISMS; CONGENITAL ADRENAL-HYPERPLASIA; DRUG; DISCOVERY; PHARMACOGENETICS; SCHIZOPHRENIA; WARFARIN; GENE;
D O I
10.1007/978-94-017-9245-5_20
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Personalized medicine has become a hot topic ascribed to the development of Human Genome Project. And currently, bioinformatics methodology plays an essential role in personal drug design. Here in this review we mainly focused on the basic introduction of the SNPs of human drug metabolic enzymes and their relationships with personalized medicine. Some common bioinformatics analysis methods and latest progresses and applications in personal drug design have also been discussed. Thus bioinformatics studies on SNPs of human CYP450 genes will contribute to indicate the most possible genes that are associated with human diseases and relevant therapeutic targets, identify and predict the drug efficacy and adverse drug response, investigate individual gene specific properties and then provide personalized and optimal clinic therapies.
引用
收藏
页码:341 / 351
页数:11
相关论文
共 50 条
  • [1] Advances in Human Cytochrome P450 and Personalized Medicine
    Chen, Qi
    Zhang, Tao
    Wang, Jing-Fang
    Wei, Dong-Qing
    CURRENT DRUG METABOLISM, 2011, 12 (05) : 436 - 444
  • [2] Human Cytochrome P450 Interactions with Redox Partner Cytochrome P450 Reductase
    Burris-Hiday, Sarah
    Chai, Mengqi
    Gross, Michael L.
    Scott, Emily
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [3] Personalized Medicine Approach to Proteomics and Metabolomics of Cytochrome P450 Enzymes: A Narrative Review
    Fetse, John
    Olawode, Emmanuel Oladayo
    Deb, Subrata
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (06) : 661 - 676
  • [4] HUMAN CUTANEOUS CYTOCHROME P450
    MERK, H
    JUGERT, F
    KUHN, A
    BONNEKOH, B
    PARK, SS
    GELBOIN, HV
    KHAN, W
    CLINICAL RESEARCH, 1989, 37 (02): : A726 - A726
  • [5] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [6] Cytochrome P450 - Versatile enzymes for medicine and biotechnology
    Urlacher V.B.
    Bernhardt R.
    BIOspektrum, 2019, 25 (7) : 715 - 718
  • [7] In vitro assessment of human cytochrome P450
    Clarke, SE
    XENOBIOTICA, 1998, 28 (12) : 1167 - 1202
  • [8] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017
  • [9] Cytochrome p450 in human brain tumours
    McFadyen, MCE
    Melvin, WT
    Murray, GI
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 153 - 153
  • [10] Cytochrome P450
    Roos, P. H.
    Jakubowski, N.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1015 - 1017